For example, macrolide treatment was shown to decrease the levels of interleukin 8 (IL-8) and/or IL-1β in bronchoalveolar lavage fluid from DPB and bronchiolitis obliterans patients [6]. The gene discussed is CXCL8; the disease is bronchiolitis obliterans syndrome.